(-0.08%) 5 142.75 points
(-0.04%) 38 542 points
(-0.02%) 17 901 points
(-0.27%) $82.41
(1.18%) $2.05
(-1.02%) $2 333.60
(-2.39%) $27.00
(-0.68%) $955.00
(0.29%) $0.935
(0.52%) $11.04
(0.27%) $0.798
(-0.26%) $93.06
Quarter results today
(amc 2024-04-30)
Expected move: +/- 6.84%
@ $16.16
发出时间: 15 Feb 2024 @ 00:52
回报率: 16.96%
上一信号: Feb 13 - 22:30
上一信号:
回报率: 5.41 %
Live Chart Being Loaded With Signals
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization...
Stats | |
---|---|
今日成交量 | 406 485 |
平均成交量 | 741 693 |
市值 | 740.40M |
EPS | $0 ( 2024-02-28 ) |
下一个收益日期 | ( $-0.400 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -13.12 |
ATR14 | $0.0160 (0.08%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-05 | Ballinger Kevin J. | Buy | 11 700 | Common Stock |
2024-03-01 | Buchanan Lucas W. | Buy | 74 954 | Common Stock |
2024-03-05 | Buchanan Lucas W. | Sell | 9 877 | Common Stock |
2024-03-05 | Ruedy Richard | Sell | 3 800 | Common Stock |
2024-03-01 | Davis Andrew S. | Buy | 62 201 | Common Stock |
INSIDER POWER |
---|
87.78 |
Last 99 transactions |
Buy: 1 575 225 | Sell: 163 491 |
音量 相关性
Silk Road Medical Inc 相关性
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Silk Road Medical Inc 相关性 - 货币/商品
Silk Road Medical Inc 财务报表
Annual | 2023 |
营收: | $177.13M |
毛利润: | $127.09M (71.75 %) |
EPS: | $-1.440 |
FY | 2023 |
营收: | $177.13M |
毛利润: | $127.09M (71.75 %) |
EPS: | $-1.440 |
FY | 2022 |
营收: | $138.64M |
毛利润: | $100.76M (72.68 %) |
EPS: | $-1.620 |
FY | 2021 |
营收: | $101.48M |
毛利润: | $76.03M (74.92 %) |
EPS: | $-1.440 |
Financial Reports:
No articles found.
Silk Road Medical Inc
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。